The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

A Mohammed, N. B Janakiram, Q Li, V Madka, M Ely, S Lightfoot, H Crawford, V. E Steele and C. V. Rao

Cancer Prevention Research 3 ( 11 ): 1417 - 1426 , 2010